These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 350227)

  • 21. Mode of action of 5-fluorocytosine and mechanisms of resistance.
    Polak A; Scholer HJ
    Chemotherapy; 1975; 21(3-4):113-30. PubMed ID: 1098864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Further evidence for sequential action of amphotericin B and 5-fluorocytosine against Candida albicans.
    Beggs WH; Sarosi GA
    Chemotherapy; 1982; 28(5):341-4. PubMed ID: 6754278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antimycotic activity in vitro and in vivo of 5-fluorocytosine on pathogenic strains of Candida albicans and Cryptococcus neoformans].
    Costa AL; Valenti A; Costa G; Calogero F
    G Batteriol Virol Immunol; 1976; 69(7-12):244-9. PubMed ID: 800772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Inhibition of thymidylate synthase in chemotherapy].
    Rode W
    Postepy Biochem; 1996; 42(2):133-40. PubMed ID: 8805186
    [No Abstract]   [Full Text] [Related]  

  • 25. trans-5-(3,3,3-Trifluoro-1-propenyl-)-2'-deoxyuridylate: a mechanism-based inhibitor of thymidylate synthetase.
    Wataya Y; Matsuda A; Santi DV; Bergstrom DE; Ruth JL
    J Med Chem; 1979 Apr; 22(4):339-40. PubMed ID: 430474
    [No Abstract]   [Full Text] [Related]  

  • 26. Fluorinated pyrimidines as tight-binding inhibitors of thymidylate synthetase.
    Danenberg PV; Lockshin A
    Pharmacol Ther; 1981; 13(1):69-90. PubMed ID: 6455671
    [No Abstract]   [Full Text] [Related]  

  • 27. A 19F nuclear magnetic resonance study of uptake and metabolism of 5-fluorocytosine in susceptible and resistant strains of Candida albicans.
    Di Vito M; Podo F; Torosantucci A; Carpinelli G; Whelan WL; Kerridge D; Cassone A
    Antimicrob Agents Chemother; 1986 Feb; 29(2):303-8. PubMed ID: 3521476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Sensitivity of yeasts against 5 fluorocytosine. Comparison of five methods (author's transl)].
    Brinkmann F
    Z Hautkr; 1981 Oct; 56(19):1255-63. PubMed ID: 7032101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation and protection from 5-fluorodeoxyuridylate inactivation of mammalian thymidylate synthetase by pyridoxal 5'-phosphate.
    Tryfiates GP
    Enzyme; 1980; 25(5):356-60. PubMed ID: 7449757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined in vitro activity of amphotericin B and 5-fluorocytosine against Cryptococcus neoformans and Candida albicans.
    Chen HH; Liushih RN; Hsieh WC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1982 May; 15(2):106-12. PubMed ID: 7047097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Sensitivity in vitro of opportunist yeasts (Candida albicans and Torulopsis glabrata) to flucytosine and concordance curves (author's transl)].
    Slim A; Bergogne-Berezin E; Courtoux D
    Ann Biol Clin (Paris); 1978; 36(2):69-74. PubMed ID: 358866
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 5-Fluorocytosine--current status with special references to mode of action and drug resistance.
    Polak A
    Contrib Microbiol Immunol; 1977; 4():158-67. PubMed ID: 342192
    [No Abstract]   [Full Text] [Related]  

  • 33. In vitro and in vivo antifungal activity of the combination methylpartricin-5-fluorocytosine.
    Strippoli V; Torosantucci A; Simonetti N
    Chemioterapia; 1984 Apr; 3(2):119-25. PubMed ID: 6398120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Interactions between 5-fluorocytosine and polyene antibiotics, resp. imidazole derivatives (author's transl)].
    Högl F; Raab W
    Mykosen; 1981 May; 24(5):261-74. PubMed ID: 6265772
    [No Abstract]   [Full Text] [Related]  

  • 35. [Sensitivity and resistance of Candida to 5-fluorocytosine. Relationship to the cell wall ultrastructure].
    Montplaisir S; Drouhet E; Nabarra B
    C R Acad Hebd Seances Acad Sci D; 1975 May; 280(19):2211-3. PubMed ID: 807407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of 5-fluorocytosine on the blastospores and hyphae of Candida albicans.
    Polak A; Wain WH
    J Med Microbiol; 1979 Feb; 12(1):83-97. PubMed ID: 372535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of thymidylate synthetase of the human lymphocytes.
    Haurani FI
    Cancer Biochem Biophys; 1979; 4(2):75-7. PubMed ID: 317899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Observations on 5-fluorocytosine and Candida albicans.
    Davies RR; Savage MA
    Sabouraudia; 1974 Nov; 12(3):302-8. PubMed ID: 4610822
    [No Abstract]   [Full Text] [Related]  

  • 39. Candida albicans resistance to 5-fluorocytosine: frequency of partially resistant strains among clinical isolates.
    Defever KS; Whelan WL; Rogers AL; Beneke ES; Veselenak JM; Soll DR
    Antimicrob Agents Chemother; 1982 Nov; 22(5):810-5. PubMed ID: 6758690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assay for yeast susceptibility to 5-fluorocytosine and amphotericin B in a frozen microtiter system.
    Ellis NS; Bartlett MS; Smith JW
    Am J Clin Pathol; 1979 Aug; 72(2):194-8. PubMed ID: 382827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.